Entering text into the input field will update the search result below

MERCK Kommanditgesellschaft auf Aktien (MKGAF) Stefan Oschmann on Q4 2020 Results - Earnings Call Transcript

Mar. 04, 2021 4:42 PM ETMerck KGaA (MKGAF), MKKGY
SA Transcripts profile picture
SA Transcripts

MERCK Kommanditgesellschaft auf Aktien (OTCPK:MKGAF) Q4 2020 Earnings Conference Call March 4, 2021 8:00 AM ET

Company Participants

Constantin Fest - Head-Investor Relations

Stefan Oschmann - Group Chief Executive Officer

Marcus Kuhnert - Group Chief Financial Officer

Kai Beckmann - Chief Executive Officer, Electronics Business Sector

Belén Garijo - Vice Chair of the Executive Board & Deputy Chief Executive Officer

Peter Guenter - Chief Executive Officer, Healthcare

Danny Bar-Zohar - Healthcare Global Head of Development

Conference Call Participants

Matt Weston - Credit Suisse

Richard Vosser - JPMorgan

Sachin Jain - Bank of America

Peter Verdult - Citi

James Quigley - Morgan Stanley

Luisa Hector - Berenberg

Simon Baker - Redburn

David Evans - Kepler Cheuvreux


Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference Call on Fourth Quarter 2020. As a reminder, all participants will be in a listen-only mode.

May I now hand you over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.

Constantin Fest

Thank you very much, Diana, and a very warm welcome to this Q4 and Full Year 2020 Earnings Call. My name is Constantin Fest. I'm Head of Investor Relations here at Merck. Please note, that presenting today are Stefan Oschmann, our group CEO; and Marcus Kuhnert, our Group CFO; as well as Kai Beckmann, CEO of our Electronics Business Sector, previously PM.

For a short introduction to the capital markets, Peter Guenter, our new CEO of our Healthcare business sector is also joining this call and will be available for the Q&A. Please note that, Danny Bar-Zohar, our Healthcare Global Head of Development is also available for questions. Lastly, I'm delighted to let you know that, Belen Garijo, Vice Chair of the Executive Board and Deputy CEO of Merck will join us for one or two minutes, after the presentation

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.